Aimmune Therapeutics Inc buy marge
Start price
20.11.17
/
50%
€31.58
Target price
01.01.19
€36.08
Performance (%)
-31.68%
End price
01.01.19
€21.58
Summary
This prediction ended on 01.01.19 with a price of €21.58. Massive losses of -31.68% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aimmune Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by marge for this prediction
In the thread Aimmune Therapeutics Inc diskutieren
marge stimmt der Outperform-Einschätzung der institutionellen Analysten zu
marge stimmt am 20.11.2017 der Outperform-Einschätzung der institutionellen Analysten zu.
- Aimmune Therapeutics (NASDAQ:AIMT) initiated with Buy rating and $60 (71% upside) price target by Roth Capital.
(Laufzeit überschritten)
Stopped prediction by marge for Aimmune Therapeutics Inc
Aimmune Therapeutics Inc
Start price
Target price
Perf. (%)
€19.28
06.09.19
06.09.19
€30.00
04.11.21
04.11.21
51.45%
05.11.21
05.11.21
